Resultados de la búsqueda 101-110 of 4231 for weakened immune system

  1. Dermatología - Ensayos clínicos - Mayo Clinic

    albicans exposure during early life on the systemic immune populations. ... The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell ...

  2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated with pathologic ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated with pathologic ...

  4. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.

  7. Cirugía de tobillo - Mayo Clinic

    Rheumatoid arthritis. This is swelling and pain in a joint caused by the immune system attacking the synovium, usually in several joints of the body. Over time ...

  8. Oncología (médica) - Ensayos clínicos

    ... Low-Grade Glioma. Rochester, Minn. The primary ... response to therapy. ... The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.